Citadel Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-23,399
Closed -$4.03M 7708
2021
Q3
$4.03M Buy
23,399
+19,564
+510% +$3.37M ﹤0.01% 2234
2021
Q2
$481K Sell
3,835
-114,943
-97% -$14.4M ﹤0.01% 4753
2021
Q1
$16.1M Sell
118,778
-286,058
-71% -$38.8M ﹤0.01% 1076
2020
Q4
$51.8M Buy
404,836
+381,052
+1,602% +$48.8M 0.01% 419
2020
Q3
$2.68M Sell
23,784
-161,299
-87% -$18.1M ﹤0.01% 2009
2020
Q2
$17.6M Buy
185,083
+144,019
+351% +$13.7M 0.01% 802
2020
Q1
$3.69M Sell
41,064
-652,319
-94% -$58.6M ﹤0.01% 1687
2019
Q4
$36.8M Sell
693,383
-92,290
-12% -$4.89M 0.02% 548
2019
Q3
$31M Buy
785,673
+473,019
+151% +$18.7M 0.01% 599
2019
Q2
$12.8M Buy
312,654
+176,511
+130% +$7.25M 0.01% 1033
2019
Q1
$6.34M Buy
+136,143
New +$6.34M ﹤0.01% 1414
2018
Q4
Sell
-18,230
Closed -$1.04M 5121
2018
Q3
$1.04M Sell
18,230
-344,329
-95% -$19.7M ﹤0.01% 2682
2018
Q2
$17.6M Buy
362,559
+202,044
+126% +$9.8M 0.01% 764
2018
Q1
$6.28M Buy
160,515
+75,696
+89% +$2.96M ﹤0.01% 1168
2017
Q4
$3.6M Sell
84,819
-152,693
-64% -$6.48M ﹤0.01% 1516
2017
Q3
$8.86M Buy
237,512
+182,963
+335% +$6.83M 0.01% 981
2017
Q2
$1.66M Sell
54,549
-100,522
-65% -$3.06M ﹤0.01% 1811
2017
Q1
$4.1M Sell
155,071
-33,607
-18% -$889K ﹤0.01% 1290
2016
Q4
$4.82M Sell
188,678
-121,895
-39% -$3.11M ﹤0.01% 1081
2016
Q3
$11.2M Buy
310,573
+140,933
+83% +$5.1M 0.01% 720
2016
Q2
$5.76M Buy
169,640
+160,977
+1,858% +$5.47M 0.01% 959
2016
Q1
$229K Sell
8,663
-213,039
-96% -$5.63M ﹤0.01% 2643
2015
Q4
$10.8M Sell
221,702
-91,613
-29% -$4.47M 0.01% 821
2015
Q3
$7.8M Sell
313,315
-74,123
-19% -$1.85M 0.01% 1006
2015
Q2
$12.3M Sell
387,438
-97,062
-20% -$3.07M 0.01% 899
2015
Q1
$18.4M Buy
484,500
+91,832
+23% +$3.5M 0.02% 728
2014
Q4
$15.3M Buy
392,668
+47,257
+14% +$1.84M 0.02% 755
2014
Q3
$10.4M Buy
345,411
+339,540
+5,783% +$10.3M 0.01% 856
2014
Q2
$199K Buy
+5,871
New +$199K ﹤0.01% 2812